Post-translational modifications (PTM) of histone proteins are critical determinants of genome function. Analysis of histone PTM levels has traditionally been performed using biochemical bulk methods to measure individual modifications. These approaches are generally unable to detect differences in
histone and histone PTM levels during the cell cycle, do not provide information on variability amongst individual cells, and they are not suitable for multiplexing to comprehensively analyze large numbers of histone modifications in single experiments. We have developed HiHiMap (High-throughput Histone Mapping), an automated high-throughput immunofluorescence technique to determine histone and histone PTM levels across the cell cycle at the single-cell level in a highly parallel format. Our approach uses imaging-based quantification of DNA content and cyclin A levels to stage individual cells in the cell cycle combined with determination of the corresponding histone and histone PMT levels in the same cells. We have applied HiHiMap to a set of 22 histone variants and histone modifications. As proof-of-principle for a biological application, we use HiHiMap to the histone and histone PTMs landscape in primary, immortalized and oncogenically transformed cells. We find differences in the behavior of a specific set of histone PTM during the the cell cycle in transformed cells compared to normal and immortalized cells. The method developed here is widely applicable to the systematic study of histone modifications in physiological and pathological settings at the single-cell level.
INTRODUCTION
Histones are among the most evolutionarily conserved proteins in eukaryotic cells.
Two copies of each core histone (H2A, H2B, H3 and H4) are assembled into octamers around which 147 base pairs of DNA are wrapped to form nucleosomes, the basic structural units of chromatin 1 . Histones are extensively modified on their N-terminal tails by post-translational modifications (PTMs), including phosphorylation on serine or threonine residues, methylation on lysine or arginine, acetylation, ubiquitylation and SUMOylation 2,3 . These modifications exert biological functions by affecting the recruitment of histone binding proteins, such as chromatin remodelers or chromatin structural proteins [4] [5] [6] . While some histone PTMs are known to be associated with active chromatin states, others are indicative of repressive chromatin 7, 8 . In addition to histone PTMs, histone variants also play an important role in the regulation of chromatin organization, for example, the replacement of canonical histones by non-allelic variants modifies nucleosome stability and chromatin dynamics 9 . Histone variants and PTMs are important for regulation of basic genomic processes including the DNA damage response (DDR), transcription and replication [10] [11] [12] [13] [14] . Due to their role in gene regulation and genome stability, histone variants and modifications have been implicated in carcinogenesis [15] [16] [17] [18] [19] .
To maintain sufficient levels of histones to ensure normal chromosomal DNA compaction throughout the cell cycle, the synthesis of DNA and of core histones is tightly coordinated. Core histone protein levels double via transcriptional upregulation during the cell cycle as the genome is duplicated in S-phase [20] [21] [22] [23] .
PTMs are generally absent on newly synthesized histones but are re-established upon DNA replication [24] [25] [26] [27] . In contrast to the histone proteins themselves, histone PTMs turn over rapidly via action of histone modifying enzymes and may thus fluctuate during the cell cycle, within a cell cycle phase and between individual cells.
The standard methods to analyze histones and histone PTMs are western blotting or stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative mass spectrometry 28 25,29-32 . These methods are limited in that they are only able to provide a population-based average measurement of histone levels or PTMs and are unable to detect differences amongst subpopulations or individual cells. While they can be used for analysis of cell-cycle fluctuations when combined with cell cycle synchronization methods, the synchronization and labeling steps require extensive culturing of cells over several days, relatively large numbers of cells, and are not suitable for parallel analysis of large numbers of modifications.
To overcome these limitations, we developed HiHiMap (High-throughput Histone Mapping), a method for single-cell quantification of histone and histone PTM levels throughout the cell cycle. The approach is based on high-throughput imaging and uses cyclin A immunofluorescence (IF) and DAPI staining for cell cycle staging which allows the accurate determination of the cell cycle stage of individual cells and, simultaneously, the measurement of histone and histone PTM levels at the single-cell level. The high-throughput nature of the method allows for parallel analysis of multiple histone PTMs in a single experiment. Using HiHIMap, we examined 22 histone and histone modifications in an oncogenic cellular transformation model [33] [34] [35] [36] and identified single cell-level changes of several histone variants and PTMs during oncogenic transformation.
Western Blot and qRT-PCR
Briefly, cells were lysed and DNA was sonicated. After determining protein concentration, 5 μg of total proteins was loaded on a NuPAGE TM NovexTM 4-12% Bis-Tris Protein Gel (ThermoFisher). After protein transfer on a PVDF membrane (Immobilon P, Millipore cat#161-0737), expression of SV40LT and H-Ras proteins was measured by incubation of this membrane with SV40LT antibody Ab101 (BD Pharmingen #554149, 1/1000), Pan-Ras antibody (Calbiochem #OP40 -final concentration 0.3 μg/mL). Intensities of protein bands, revealed by chemiluminescent reagents, were measured using a ChemiDocTM MP imaging system from BioRad. The expression of Pan-Ras and SV40LT was normalized to the endogenous expression of GAPDH.
For real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), total cellular RNA was isolated using the RNeasy kit according to the manufacturer's instructions (Qiagen, cat#74136). The first-strand cDNA was synthesized from 0.5 μg RNA using random primers and MultiScribe reverse transcriptase (from high capacity cDNA reverse transcription kit #4368813, Applied Biosytems). RNA concentration and purity were determined by UV spectrophotometry (Nanodrop). The primer pairs used were as follows: hTERT-F:
5′GAGCTGACGTGGAAGATGAG3′;
hTERT-R: 
Image Acquisition
Imaging was performed on an Opera QEHS high-content screening microscopy system (PerkinElmer) running Opera 2.0.1 software using a 40X water immersion (NA 0.9) or a 20X water immersion (NA 0.7) objective lens and three 12-bit 1. 
Automated Image analysis
Acquired images were analyzed with Columbus 2.5 or 2.6 (PerkinElmer) software.
Nuclei were detected and non-nuclear objects representing nuclear debris and/or nuclear segmentation errors were eliminated by manually setting nuclear area and roundness filters. The resulting nucleus region of interest was then used as the search region to measure integrated and mean fluorescence intensities of DAPI, cyclin A and histone or PTM of interest in the UV, Alexa 488 and Alexa 647 channels, respectively.
Single cell image analysis results were exported as tab separated text files and further analyzed with R statistical analysis software (https://cran.r-project.org/).
Cell cycle phases G1, S and G2/M were determined as described previously 38 using the DAPI intensity levels. In addition, we identified G2 cells by the marker protein cyclin A2.
Cell cycle profiling by imaging
For the high-throughput microscopy pipeline, a dedicated R script was generated.
First, the cell cycle profiles for each well based on the DAPI integrated intensity were plotted and, after a visualization of the range of G1 and G2 peak values in different wells, the positions of the peak maxima were calculated using a nonparametric mixed model estimation in the R mixtools package 39 or by manually determining the positions of the peaks when the model was unable to calculate them. The G1 peak value was set to 1 in order to define the same thresholds for G1, S and G2/M phases in all samples ( Fig.S1 ). After plotting a histogram for the cyclin A intensity values, the cyclin A threshold for all wells of a 384-well plate was manually defined based on the background staining in the wells incubated without cyclin A antibody but with the secondary antibodies. Then, the cell cycle stage associated with each individual cell in the dataset was determined based on both cyclin A and DAPI thresholds. Boxplots overlaid with dot plots of the integrated intensity of a histone or PTM at each cell cycle phase were created and text files containing the geometric mean integrated intensity and mean fluorescence intensity for each histone and PTM studied at each cell cycle stage were generated.
To compare the levels of histones and histone PTMs in primary, immortalized and transformed cells, several steps were added to the R script. To take into consideration the ploidy status of the transformed cells, the histone and histone PTM levels were normalized to the DAPI amount. To simplify the representation of the results, we show results for tetraploid cells, which is the major population of transformed cells. For example, the transformed cells of the AG06289 sample displayed a mixed population of diploid and tetraploid cells. The tetraploid cells represent the main population and their histone and histone PTM levels are indicated in the graphs. Note that after normalization to the DNA amount, the results for the tetraploid and diploid cells gave similar results.
Cell cycle profiling by flow cytometry
Cell cycle distribution was assessed by measuring the DNA content of a suspension of fresh nuclei by flow cytometric analysis after PI staining. Cells from one 60-80% confluent 10 cm-dish were washed with PBS. The supernatant was discarded, and cells were resuspended in 50 μL of PBS and fixed with 450 μL of 70% ethanol for 30 minutes at 4°C and then stored at -20°C. After ethanol elimination, cells were washed twice with PBS and labeled with PI (Sigma #P4864)
in the presence of RNase A (Sigma, 100 mg/mL), scanned by flow cytometry using a FACS Calibur and analyzed using BD Cell Quest Pro software.
Statistical analysis
Bar chart results are represented as means ± 1 SD (standard deviations) of a minimum of three biological replicates. For comparisons of histone and histone PTM levels between groups, results are represented as notched box plots using R 40 and the ggplot2 package 41 . Box plot notches indicate the estimated 95% confidence interval (CI) for the estimated median value, calculated as ± 1.58 × IQR/√n, where IQR is the interquartile range or distance between the first and third quartiles, and n is the number of cells 42 . The lower and upper hinges of the boxplots correspond to the first and third quartiles (the 25 th and 75 th percentiles). The upper and lower whiskers extend from the hinge to ± 1.5 * IQR of the hinge.
The Student's t test was used for all pairwise comparisons and p-values were adjusted using the Benjamini-Hochberg multiple test correction. P<0.05 was considered statistically significant for these analyses. All statistical analyses were performed using R statistical analysis software.
RESULTS

HiHiMap Outline
We sought to develop a method to measure the levels of histone and histone PTMs through the cell cycle at the single-cell level and in a high-throughput format to enable comprehensive analysis of the epigenetic landscape in individual cells.
HiHiMap is a high-throughput imaging-based approach in which DAPI and cyclin A IF staining is used to stage individual cells in the cell cycle and this information is combined with the use of antibody-based quantitative detection of histones and
histone PTMs in the same individual cells ( Fig. 1 ).
For HiHiMap, cells are plated in 384-well imaging plates, fixed in 4% paraformaldehyde and stained for cyclin A and a histone or histone PTM of interest for each well using specific antibodies (see Materials and Methods). Each individual nucleus is assigned to a cell cycle stage based on integrated DAPI intensity and cyclin A staining and the corresponding histone or histone PTM levels are measured in each cell-cycle staged nucleus. Results are represented as single-cell datasets ( Fig. 1 ). As proof-of-principle, HiHiMap was applied to the analysis of 26 histones, histone variants and histone PTMs (Table S1 ).
Cell cycle staging
Single cells are staged in the cell cycle by measurement of the integrated DAPI intensity of an individual cell nucleus as previously described 38 . We have previously demonstrated the accuracy of cell cycle staging by DAPI using this approach by direct comparison with FACS analysis 38 . Typical imaging-based DAPI intensity distributions are bi-phasic with peak 1 (arbitrarily defined as intensity value 1; see Methods) representing pre-replicative G1 cells 38 . To unambiguously stage individual cells, DAPI intensity was combined with cyclin A signal, which is known to be elevated in S-and G2-phase 43 S1 ).
HiHiMap validation using core histones
To validate HiHiMap, we measured the level of three nuclear proteins with known cell cycle behavior in hTERT immortalized CRL-1474 human dermal fibroblasts (HDF) 36, 44 . Histone H4 is a core histone whose intensity level is known to follow DNA content during the cell cycle [21] [22] [23] . As expected, histone H4 levels increase 1.87 ± 0.03 (mean ± SD) and 2.3 ± 0.03-fold in S and G2 phases, respectively, in comparison to G1 phase cells ( Fig. 2B and C). Results were highly reproducible in technical and biological replicates ( Fig. S2 ). Phosphorylation on Serine 10 of histone H3 (H3S10Ph) is a well-characterized mitotic marker 45 . As expected, a major increase of H3S10ph levels was found in G2/M phase (9.2 ± 0.7-fold) in comparison to G1 cells ( Fig. 2E and F) . As a negative control, the transcription factor LHX9, involved in brain development 46 , does not vary with DNA levels in HDF and we only observe a marginal increase in the LHX9 level during the cell cycle (ratios S/G1=1.2 ± 0.01; G2/G1=1.3 ± 0.02 and M/G1=1.6 ± 0.08) ( Fig. 2H and I).
Analysis of core histones and variants during the cell cycle
To extend our analysis of histones, we measured the levels of all core histones ( Fig.   3A ). Protein levels of H2A, H2B, H3 and H4 increased in S phase by 1.7 ± 0.02-, 1.4 ± 0.02-, 2.0 ± 0.03-and 1.87 ± 0.03-fold, respectively, and 2.3 ± 0.03-, 1.84 ± 0.03-, 2.6 ± 0.04-, 2.3 ± 0.03-fold, respectively, in G2 phase relative to G1 before decreasing 1.7 ± 0.09-, 1.7 ± 0.08-, 1.6 ± 0.09-and 1.7 ± 0.09-fold during mitosis in comparison to G2 phase (Fig. 3A) . The 2.6-fold increase in histone H3 level reflects detection of multiple H3 isoforms (H3.1, H3.2 and H3.3) by the antibody used ( Fig. 3A ). We conclude that HiHiMap accurately detects cell-cycle related fluctuations in histones and histone PTMs.
In contrast to the canonical histones, the synthesis of histone variants is uncoupled from DNA replication 47 . To characterize the cell cycle behavior of histone variants we applied HiHiMap to several histone variants ( Fig. 3B ). Levels of the H3 variant H3.3 and the H2A variant H2AZ levels only increased 1.3 ± 0.07-and 1.2 ± 0.13fold from G1 to S phase and 1.3 ± 0.02-and 1.4 ± 0.02-fold to G2 before reaching a 1.7 ± 0.02-and 1.9 ± 0.09-fold increase in M phase ( Fig. 3B ). MacroH2A1 showed no increase from G1 to S and G2 phases (S/G1=1 ± 0.02; G2/G1=1 ± 0.03) followed by a 1.7 ± 0.12-fold increase between G2 and M. In contrast to other variants, H2AX, showed larger fluctuations from G1 to S and to G2 with 1.4 ± 0.02-and 1.7 ± 0.03-fold increases, respectively, followed by a slight decrease in mitosis (1.6 ± 0.07-fold decrease). Interestingly, the H2AX gene (H2AFX) contains features of both replication-dependent and replication-independent histone species, in that it is encoded by a small intronless gene and has the stem-loop structure that is characteristic of replication-linked histones 48 . We conclude that, in contrast to core histones, levels of several histone variants, except H2AX, do not follow cellular DNA levels. Using a set of specific, previously characterized, antibodies (Table S1 ), we detect the rapid increase after DNA replication of several H3K4 methylation events.
Characterization of cell-cycle fluctuations of histone modifications
S/G1 ratios of mono-, di-and tri-methylation of H3K4 were increased 1.7 ± 0.03-,
1.6 ± 0.03-and 1.7 ± 0.02-fold, respectively, to reach a two-fold increase in G2
(H3K4-me1: ratio S/G1 = 2.1 ± 0.04; -me2: 1.9 ± 0.04; -me3: 2.1 ± 0.03) and then decreased in mitosis (ratios M/G1: 1.4 ± 0.01-fold, 1.6 ± 0.01-fold and 1.7 ± 0.09fold for mono-, di-and tri-methylation, respectively (Fig. 4A ). The level of H3K9me1, commonly associated with transcriptional activation 49 , followed the same pattern as H3K4 methylation during the cell cycle with its highest level in G2 phase (ratio S/G1=1.5 ± 0.02: ratio G2/G1= 2 ± 0.03; ratio M/G1=1.5 ± 0.09) ( Fig. 4A ). In contrast, the higher methylation states of H3K9, which are linked to transcriptional repression 50 , modestly increased from G1 to S (ratio S/G1=1.2 ± 0.01 for H3K9me2, ratio S/G1=1.3 ± 0.02 for H3K9me3) ( Fig. 4A ) and for H3K9me2
and H3K9me3 we observed 1.5 ± 0.02-and 1.4 ± 0.02 -fold increases, respectively, in G2 phase and a 1.8 ± 0.07-and 2 ± 0.01--fold increase, respectively, in M phase compared to G1 (Fig. 4A ). H3K27me3, one of the most prominent repressive histone marks 49,51 increased by 1.6 ± 0.03-and 1.7 ± 0.04-fold in S and G2 phases, respectively, before dropping off to a 1.3 ± 0.08-fold increase in mitosis in comparison to G1 (Fig. 4A ). H3K36me3, which is enriched in the transcribed regions of actives genes 52, 53 , slightly increases during the cell cycle (ratios S/G1:
1.12 ± 0.02; G2/G1:1.24 ± 0.02) before a 1.61 ± 0.01 increase in mitosis compared to G1 (Fig. 4A ). Furthermore, mono-and di-methylated H4K20, involved in DNA replication and DNA repair 54 , modestly increased from G1 into S-phase (ratios S/G1: 1.2 ± 0.03 for H4K20me1 and 1.1 ± 0.01 for H4K20me2) before increasing in G2 phase (ratios G2/G1: 2.5 ± 0.08) for H4K20me1 and in mitosis for H4K20me2
(1.73 ± 0.09) (Fig. 4B) .
In contrast to the methylation levels, analysis by HiHiMap of H3K9Ac, H4K5Ac, and H3 and H4 global acetylation levels showed increases between G1 and S phases (ratio S/G1=1.52 ± 0.02 for H3K9Ac; 1.5 ± 0.02 for H4K5Ac; 1.5 ± 0.02 for H3Ac; 1.5 ± 0.02 for H4Ac), and even further after DNA synthesis leading to a twofold ratio between G2 and G1 phases (ratio G2/G1=2 ± 0.025 for H3K9Ac; 2 ± 0.037 for H4K5Ac; 2.1 ± 0.04 for H3Ac; 1.9 ± 0.03 for H4Ac) followed by a slight decrease in mitosis (ratio M/G1=1.86 ± 0.07 for H3K9Ac; 1.73 ± 0.01 for H4K5Ac; 1.7 ± 0.01 for H3Ac; 1.6 ± 0.1 for H4Ac) (Fig. 5A, B) . These observations delineate the cellcycle behavior of a comprehensive sets of histone modifications at the single-cell level.
Identification of dysregulated histone and histone post-translational modifications during oncogenic transformation
To apply HiHiMap to a biological problem, we took advantage of the capacity of
HiHiMap for multiplexing to systematically analyze histones and histone modifications during oncogenic transformation. To generate oncogenically transformed cells we in vitro-transformed primary human skin fibroblasts from three individuals by introduction of hTERT, H-RasV12 and SV40 Large-T (LT) and
Small-T (ST) antigens as previously described [33] [34] [35] [36] (Fig. S3 ). We confirmed the presence of the three transgenes at the RNA (Fig. S3A ) and protein (Fig. S3B ) levels
and their ability to form colonies in soft agar at high rates (Fig. S3C ). Comparative profiling of the cell cycle distribution of primary, immortalized and transformed cells by DAPI staining revealed the expected high levels of aneuploidy in the transformed cells with the shift of the cell cycle profile towards higher levels of DAPI integrated intensity (Fig. S4, 5) . These results were confirmed by flow cytometry (Fig. S4 ).
To account for the tetraploid nature of transformed cells, the DAPI thresholds to stage cells were modified and diploid G2 cells were defined as cells with DAPI Figure   6 . We normalized the levels of core histones and histone variants to the DNA content ( Fig. 6C ). We observed an increase of 2.1 ± 0.02-, 1.5 ± 0.07-, 1.4 ± 0.04-and 2.7 ± 0.03-fold in the level of H2AX variant in G1, S, G2 and M, respectively, between the primary and transformed cells (p < 10 -14 for each cell cycle stage, Student's t-test) and an increase of 2.6 ± 0.03-, 1.7 ± 0.05, 1.8 ± 0.03-and 3.3 ± 0.08fold in the level of this variant between the immortalized cells and their transformed counterparts in G1, S, G2 and M (p < 10 -16 , Student's t-test), respectively ( Fig. 6C, Fig. 7A ). In contrast, we observed a slight decrease of 0.81 ± 0.04-(p < 10 -16 ), 0.87 ± 0.15-(p = 0.07), 0.81 ± 0.09-(p = 4.59 x 10 -5 ) and 0.82 ± 0.11fold (p = 0.001, Student's t-test) in the levels of H2AX between the primary and immortalized cells in G1, S, G2 and M phases, respectively. Representative results for a single cell line (AG06310) are shown and all results were confirmed in three independent experiments in HDFs from three individuals (Fig. 6, Fig. S8, Fig. S9 ).
For analysis of modifications of histones H3 and H4, we normalized their levels to the levels of the corresponding core histone to account for the observed aneuploidy in individual cells and to account for the variations in the levels of core histones between samples ( Fig. 6A and B) . After normalization to H3, H3K9me2 We observed a statistically significant decrease of 0.6 ± 0.04-(p < 10 -16 ) and 0.53 ± 0.12-fold (p < 10 -16 ) in the level of H4K20me2 normalized to H4 between primary and transformed cells as well as a decrease of 0.6 ± 0.04-(p < 10 -16 ) and 0.59 ± 0.12fold (p=1.33x10 -5 ) between immortalized and transformed cells in G1 and M phases, respectively ( Fig. 6B and 7C ). All results were confirmed in three independent experiments and similar results were observed in HDFs from three individuals ( Fig. 6, Fig. S8, Fig. S9 ).
HiHiMap was also able to detect differences in the behavior of individual histones and histone modifications across the cell cycle ( Fig. 8 ). to G1, respectively, in primary and immortalized cells (Fig. 7C, Fig. 8C ). In contrast, the level of H2AZ varies considerably in S and G2 phases of transformed cells (1.6 ± 0.02-fold, p<10 -16 in S and 2 ± 0.01-fold, p<10-16 in G2), and varies less in their primary (1.4 ± 0.01-fold, p=7.1x10 -11 in S; 1.6 ± 0.01-fold, p<10- 16 in G2) and immortalized (1.3 ± 0.01-fold, p=7.6x10 -6 in S; 1.5 ± 0.01-fold, p<10 -16 in G2) counterparts ( Fig. 7C, Fig. 8C ). All results were confirmed in three independent experiments and similar results were observed in HDFs from three individuals ( Fig. 7, Fig. 8, Fig. S10, Fig. S11 ). These results point to considerable effects on histone and histone modifications during oncogenic transformation.
DISCUSSION
We have developed an imaging-based method, termed HiHiMap, to quantitatively measure histone and histone PTM levels throughout the cell cycle at the single-cell level using high-throughput microscopy. For validation we show that HiHiMap is able to detect several expected changes in histones and histone Most importantly, HiHiMap is a single-cell analysis method and, in contrast to biochemical methods which use bulk analysis and generate population averages, it measures histone and histone PTM in single cells whose position in the cell cycle has been determined. The method thus allows the study of the behavior of subpopulations of cells and of the variability within a population. For example, we find much greater variability in the single-cell distribution of histone and PTM levels in transformed cells than within the primary or immortalized populations (Fig. 7A ). In addition, pooling of single cell data across the typically 1,000-2,000
analyzed cells also allows derivation of population averages, making the data comparable to biochemical datasets.
A limitation of HiHiMap is that it cannot distinguish between free and bound histones in the nucleus as well as between the same modifications on multiple isoforms of core histones. In addition, HiHiMap also does not distinguish preexisting from newly deposited histones or histone modifications after DNA replication. Furthermore, the method requires use of antibodies for detection.
However, the abundance of well-characterized antibodies against a wide array of histones and histone modifications in various species lessens this concern.
We validated HiHiMap using several replication-dependent histones and demonstrate accurate detection of their expected increases. As proof-of-principle for its application as a discovery tool, we investigated global changes of histone and histone PTM levels during oncogenic transformation. In an established cellbased transformation model we find a number of changes in histones and histone modifications over the course of oncogenic transformation, pointing to potential biological mechanisms. Of significance, we find reduction of H3K9me2, which is known to characterize condensed heterochromatin, and thus gene inactivation 49, 58, 59 , and has recently been shown to be decreased in an in vitro tumor transformation model of human primary mammary cell and in breast cancer tissues 60 . Similarly, global levels of H3K9 dimethylation are significantly lower in bladder cancer than in normal urothelial tissue, and levels in muscle invasive bladder cancer are lower compared to non-muscle invasive bladder cancer 61 . In prostate 62 and kidney cancers 16 as well as in clear cell renal cell carcinoma 63 , lower levels of H3K9me2 have been associated with disease outcome and predict poor prognosis. We also found a decrease in H4K20 dimethylation, the most abundant methylation mark on histone H4 in proliferating cells 29 , which has been linked to DNA damage and DNA repair 64 and genomic instability 54 . In agreement with our results, hypomethylation of H4K20me2 has been shown in metastatic and castration-resistant prostate cancer compared to normal prostate tissue 65 and in several other cancers including bladder 66 and liver 67 tumors. Finally, we found increased levels of H2AX in transformed cells compared to their primary and immortalized counterparts. The histone variant, H2AX, has been implicated in tumor development by virtue of frequent mutations and deletions of chromosome region 11q23, which contains the H2AX gene, in a large number of human cancers, especially in hematopoietic malignancies 70, 71 and head and neck squamous cell carcinoma 72 and H2AX knockout mice show increased genomic instability and a higher risk of developing cancers 73 . In addition, phosphorylation of H2AX plays a key role in the DNA damage response 74 and its levels are increased in many cancer cells [75] [76] [77] [78] .
In summary, we have developed a versatile method to measure in individual cells the levels of multiple histone and histone PTMs throughout the cell cycle. We validated the method and applied it to identify changes in histones and histone modifications during oncogenic transformation. We anticipate that HiHiMap will be a useful tool to study the regulation of histone and histone PTM levels through the cell cycle in a wide range of physiological and pathological conditions. 
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